Duet BioTherapeutics Inc. — Form D
Duet BioTherapeutics Inc. of PASADENA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-31. $230K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-31
- Form: D
- Accession: 0000945621-22-000372
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $230K
- Investors: 17
- Date of first sale: 2022-10-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-463398
Issuer
- Name: Duet BioTherapeutics Inc.
- CIK: 0001952143
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 251 SOUTH LAKE AVENUE, PASADENA, CA, 91101
- Phone: 626-214-8082
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Robert J Gibson | Director | New York, NY |
| Ira Scott Greenspan | Director | New York, NY |
| Raphael Scott Hofstein | Director | New York, NY |
| Alan Horsager | Director | Pasadena, CA |
| Joshua J Lamstein | Director | New York, NY |
| Alan Horsager | Executive Officer | Pasadena, CA |
More